The largest shareholder group is systematically reducing its stake with no insider buying to counterbalance. Monitor for additional MPM sales in coming weeks and any catalyst that might explain the exit, upcoming pipeline data or partnership news could be the driver. The selling is material enough to pressure the stock near-term.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 10 $6.42entry
- T+1 · 2mo ago +5.92%α +5.07% · $6.80
- T+5 · 2mo ago +7.48%α +7.98% · $6.90
- T+20 · 6w ago −13.86%α −15.99% · $5.53
- T+47 · todayOpen
- T+60 · in 17d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two MPM BioVentures funds (10% owners) sold a combined $547K in TRDA shares over two days, part of a larger 7-day cluster totaling $3.8M. The selling is concentrated at the largest shareholder level, not C-suite, and represents ~1.3% of market cap, a material reduction by a single insider group. No insider buying offsets this, and the pattern suggests systematic portfolio reduction rather than opportunistic timing.
Key Financial Metrics
Key Facts
- MPM BioVentures 2014 and 2018 funds sold 77,000 shares combined at $7.11 on 2026-09-04, totaling $547K
- The same funds sold an additional $3.26M in TRDA on 2026-09-08 and 2026-09-09, bringing the 7-day cluster to $3.8M
- Total 7-day selling represents ~1.3% of TRDA's $293M market cap
- No insider purchases were reported in the cluster
- All sales are open-market (Code S), not tax-withholding or derivative exercises
Financial Impact
$3.8M in open-market sales over 7 days, ~1.3% of market cap
Risk Factors
- Continued selling by MPM BioVentures could further pressure the stock
- No insider buying suggests management/board are not stepping in to signal confidence
- Large shareholder exit may indicate negative non-public information about pipeline or financials
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TRDA-1788999611457 |
Track record
21 reports on TRDA
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +58.22% at T+20 after the May 4, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Neutral 4/10 No price data
- Nov 5, 202611d ago Press Release Neutral 4/10 Entry $4.55 Now $5.00 +9.89% settles Feb 3
- Oct 14, 20264w ago 8-K Bullish 6/10 Entry $4.55 Now $5.00 +9.89% settles Jan 11
- Sep 9, 20269w ago Insider Cluster Bearish 6/10 Viewing Entry $6.42 Now $5.00 +22.12% settles Dec 4
- Sep 3, 202610w ago Insider Cluster Neutral 3/10 Entry $7.13 Now $5.00 −29.87% settles Dec 1
- Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 31, 202611w ago Insider Cluster Neutral 3/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 26, 202611w ago Insider Cluster Neutral 3/10 Entry $7.27 Now $5.00 −31.22% settles Nov 20
- Aug 10, 202614w ago Insider Cluster Neutral 2/10 Entry $7.04 to $5.06 Now $5.00 −28.98% ▼ −28.13% −27.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers